Lymecycline
Especificaciones
992-21-2Número CAS
(2S)-6-[[[(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]methylamino]-2-aminohexanoic acidNombre IUPAC
C29H38N4O10Fórmula química
602.6 g/molPeso molecular
Lymecycline; 992-21-2; Mucomycin; Tetralysal; Limeciclina; Lymecyclinum; N-Lysinomethyltetracycline; Tetracycline-L-methylenelysine; Ciclolysal; Ciclolysine; Tetracycline-L-methylene lysine; Tetracyclinemethylenelysine; Lymecycline (INN); Lymecycline (85%); (+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide; 7D6EM3S13P; (2S)-6-[({[(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracen-2-yl]formamido}methyl)amino]-2-aminohexanoic acid; (2S)-6-[[[(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]methylamino]-2-aminohexanoic acid; N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine; N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline; Tetralisal; Armyl; LYMECYCLINE [INN]; L-Lysine,N6-[[[[(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenyl]carbonyl]amino]methyl]-; N(6)-[({[(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracen-2-yl]carbonyl}amino)methyl]-L-lysine; Infaciclina; Lisinbiotic; Vebicyclysal; Ciclisin; Tetraciclina-L-metilenlisina; Lymecycline [INN:BAN]; C29H38N4O10; Lymecyclinum [INN-Latin]; Limeciclina [INN-Spanish]; Tetracycline, lysinomethyl-; UNII-7D6EM3S13P; EINECS 213-592-2; Tetraciclina-L-metilenlisina [Italian]; LYMECYCLINE [MI]; LYMECYCLINE [MART.]; LYMECYCLINE [WHO-DD]; SCHEMBL149162; orb1705786; tetracycline-L Methylene-Lysine; CHEMBL2103929; SCHEMBL23248015; SCHEMBL29800028; CHEBI:59040; GTPL10912; AHEVKYYGXVEWNO-UEPZRUIBSA-N; PZTCVADFMACKLU-UEPZRUIBSA-N; LYMECYCLINE [EP MONOGRAPH]; N(sup 2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline; EBC-27373; AKOS016340328; DB00256; KS-1366; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, lysinemethylene deriv.; DA-65161; FL164019; HY-106339; CS-0025613; D06884; T20164; EN300-19790903; Q897051; N2-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline; (2S)-6-[[[(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]methylamino]-2-amino-hexanoic acid; (S)-2-amino-6-((((4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamido)methyl)amino)hexanoic acid; L-Lysine, N6-(((((4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenyl)carbonyl)amino)methyl)-; L-Lysine, N6-((((4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenyl)carbonyl)amino)methyl)-, (4S-(4alpha,4aalpha,6beta,12aalpha))-; Lysine, N(sup 6)-((4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)-, (+)-Sinónimos
